Literature DB >> 6126493

Benzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interactions.

E M Sellers, U Busto.   

Abstract

Ethanol and benzodiazepines interact both pharmacokinetically and pharmacodynamically. However, the importance of these effects has been exaggerated. Kinetically, acute doses of ethanol impair the disposition of benzodiazepines that are metabolized by demethylation or hydroxylation, but not those that undergo glucuronide conjugation. On the other hand, chronic ethanol administration increases the clearance of benzodiazepines that are demethylated or hydroxylated. The pharmacodynamics of the ethanol-benzodiazepine combination is less clear. The sedative and psychomotor effects of the combination appear to be enhanced, compared to the effects of the drugs given alone. However, it is difficult to assess the proportion of the observed effects that is due to benzodiazepines, as ethanol appears to be the dominant partner in this combination. Studies attempting to control for this imbalance have been so hampered by methodological problems that no firm conclusions can be drawn. Moreover, a number of benzodiazepines have not been studied in combination with ethanol. We suggest, however, that the ethanol-benzodiazepine interaction is probably less important than those involving ethanol and other psychotropic drugs, such as cannabinoids, neuroleptics, stimulants, and antidepressants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126493

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  20 in total

Review 1.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

2.  Pattern of acute intoxication in Florence: a comparative investigation.

Authors:  P F Mannaioni
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 3.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

4.  Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.

Authors:  A L van Steveninck; R Gieschke; H C Schoemaker; M S Pieters; J M Kroon; D D Breimer; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  A comparison between chlordiazepoxide and CL 218,872--a synthetic nonbenzodiazepine ligand for benzodiazepine receptors on spontaneous locomotor activity in rats.

Authors:  J F McElroy; R L Fleming; R S Feldman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Effects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

Authors:  M Linnoila; J M Stapleton; R Lister; H Moss; E Lane; A Granger; D J Greenblatt; M J Eckardt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

Review 9.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

10.  Disposition of clotiazepam: influence of age, sex, oral contraceptives, cimetidine, isoniazid and ethanol.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs; J S Harmatz; H Grehl
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.